China · Delayed Price · Currency is CNY BMC Medical Statistics
Total Valuation
BMC Medical has a market cap or net worth of CNY 5.76 billion. The enterprise value is 3.34 billion.
| Market Cap | 5.76B |
| Enterprise Value | 3.34B |
Important Dates
The next confirmed earnings date is Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
BMC Medical has 123.44 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 123.44M |
| Shares Outstanding | 123.44M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | -1.65% |
| Owned by Insiders (%) | 29.41% |
| Owned by Institutions (%) | 20.98% |
| Float | 56.64M |
Valuation Ratios
The trailing PE ratio is 26.28 and the forward PE ratio is 20.15.
| PE Ratio | 26.28 |
| Forward PE | 20.15 |
| PS Ratio | 4.18 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | 43.19 |
| P/OCF Ratio | 33.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.33, with an EV/FCF ratio of 25.05.
| EV / Earnings | 15.12 |
| EV / Sales | 2.42 |
| EV / EBITDA | 11.33 |
| EV / EBIT | 12.22 |
| EV / FCF | 25.05 |
Financial Position
The company has a current ratio of 6.28, with a Debt / Equity ratio of 0.06.
| Current Ratio | 6.28 |
| Quick Ratio | 5.66 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | 1.45 |
| Interest Coverage | 116.58 |
Financial Efficiency
Return on equity (ROE) is 7.58% and return on invested capital (ROIC) is 37.09%.
| Return on Equity (ROE) | 7.58% |
| Return on Assets (ROA) | 4.80% |
| Return on Invested Capital (ROIC) | 37.09% |
| Return on Capital Employed (ROCE) | 8.87% |
| Weighted Average Cost of Capital (WACC) | 6.44% |
| Revenue Per Employee | 1.49M |
| Profits Per Employee | 239,315 |
| Employee Count | 923 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 4.01 |
Taxes
In the past 12 months, BMC Medical has paid 39.75 million in taxes.
| Income Tax | 39.75M |
| Effective Tax Rate | 14.86% |
Stock Price Statistics
The stock price has decreased by -21.23% in the last 52 weeks. The beta is 0.43, so BMC Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -21.23% |
| 50-Day Moving Average | 45.83 |
| 200-Day Moving Average | 50.33 |
| Relative Strength Index (RSI) | 55.98 |
| Average Volume (20 Days) | 1,593,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMC Medical had revenue of CNY 1.38 billion and earned 220.89 million in profits. Earnings per share was 1.77.
| Revenue | 1.38B |
| Gross Profit | 732.39M |
| Operating Income | 273.21M |
| Pretax Income | 267.40M |
| Net Income | 220.89M |
| EBITDA | 285.33M |
| EBIT | 273.21M |
| Earnings Per Share (EPS) | 1.77 |
Balance Sheet
The company has 2.62 billion in cash and 192.64 million in debt, with a net cash position of 2.43 billion or 19.69 per share.
| Cash & Cash Equivalents | 2.62B |
| Total Debt | 192.64M |
| Net Cash | 2.43B |
| Net Cash Per Share | 19.69 |
| Equity (Book Value) | 3.07B |
| Book Value Per Share | 24.78 |
| Working Capital | 2.68B |
Cash Flow
In the last 12 months, operating cash flow was 173.63 million and capital expenditures -40.32 million, giving a free cash flow of 133.31 million.
| Operating Cash Flow | 173.63M |
| Capital Expenditures | -40.32M |
| Depreciation & Amortization | 12.12M |
| Net Borrowing | -179.56M |
| Free Cash Flow | 133.31M |
| FCF Per Share | 1.08 |
Margins
Gross margin is 53.13%, with operating and profit margins of 19.82% and 16.02%.
| Gross Margin | 53.13% |
| Operating Margin | 19.82% |
| Pretax Margin | 19.40% |
| Profit Margin | 16.02% |
| EBITDA Margin | 20.70% |
| EBIT Margin | 19.82% |
| FCF Margin | 9.67% |
Dividends & Yields
This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 1.01%.
| Dividend Per Share | 0.47 |
| Dividend Yield | 1.01% |
| Dividend Growth (YoY) | 131.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 27.94% |
| FCF Payout Ratio | 61.11% |
| Buyback Yield | -0.22% |
| Shareholder Yield | 0.79% |
| Earnings Yield | 3.84% |
| FCF Yield | 2.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BMC Medical is 63.50, which is 36.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 63.50 |
| Price Target Difference | 36.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 22.93% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 28, 2026. It was a forward split with a ratio of 1.4.
| Last Split Date | May 28, 2026 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
BMC Medical has an Altman Z-Score of 10.33 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.33 |
| Piotroski F-Score | 6 |